TimesSquare Capital Management’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$29M	Buy	112,342 +14,942	+15%	+$3.98M	0.49%	78
2025 Q4	$24M	Sell	97,400 -21,114	-18%	-$4.44M	0.36%	102
2025 Q3	$20.9M	Buy	118,514 +4,310	+4%	+$645K	0.3%	116
2025 Q2	$15.7M	Sell	114,204 -27,979	-20%	-$4.11M	0.23%	125
2025 Q1	$25.6M	Sell	142,183 -16,685	-11%	-$2.81M	0.41%	87
2024 Q4	$24.9M	Buy	158,868 +44,646	+39%	+$7.92M	0.36%	107
2024 Q3	$20.8M	Buy	114,222 +31,183	+38%	+$6.01M	0.31%	115
2024 Q2	$15.2M	Sell	83,039 -14,122	-15%	-$2.37M	0.24%	126
2024 Q1	$17.3M	Sell	97,161 -153,309	-61%	-$21.3M	0.25%	130
2023 Q4	$31.1M	Buy	250,470 +127,435	+104%	+$14.1M	0.46%	90
2023 Q3	$14.3M	Buy	+123,035	New	+$15M	0.22%	132